Genomics in Cancer Care Market Opportunities 2031
Genomics is the study of genes and other molecular components that aids in the identification of genetic features and functions of cells. Genomic analysis is a frequently utilised biotechnological tool that has shown a variety of therapeutic and medicinal benefits. In the medical sector, genomics has made it possible to research cancer and its genetics more efficiently and conveniently. The application of genomics has resulted in the development of novel cancer treatments and preventative measures.
MARKET SCOPE
The Global Genomics In Cancer Care Market Analysis to 2031 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the genomics in cancer care market with detailed market segmentation by product and service, technology, application and end user. The report provides key statistics on the market status of the leading genomics in cancer care market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on product and service the market is segmented as, instruments, consumables, and service, software.
- Based on technology the market is segmented as, gene sequencing, PCR, microarray nucleic acid extraction and purification, and others.
- Based on application the market is segmented as, diagnostic, drug delivery, precision medicine, and research.
- Based on end user the market is segmented as, hospitals, diagnostics laboratories, and academic & research institutes.
MARKET DYNAMICS
Drivers:
- Increasing prevalence of cancers across the globe.
- Developments and technological advancements in the field of genomics is expected to spur the market growth.
- Rising R&D expenditures by biopharmaceutical and biotechnological companies to develop precision medicine for cancers.
Restraints:
- However, availabilty of other approaches, high cost associated with genomics study are expected to restrain market growth.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The genomics in cancer care market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the genomics in cancer care market in these regions.
IMPACT OF COVID-19 ON GENOMICS IN CANCER CARE MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The genomics in cancer care market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the genomics in cancer care market in these regions.
IMPACT OF COVID-19 ON GENOMICS IN CANCER CARE MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the genomics in cancer care market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from genomics in cancer care market are anticipated to lucrative growth opportunities in the future with the rising demand for Genomics in cancer care in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the genomics in cancer care market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Illumina Inc
- Agilent Technologies, Inc
- Thermo Fisher Scientific Inc
- PerkinElmer, Inc.
- QIAGEN
- Abbott
- BGI
- F. Hoffmann La Roche AG
- Bio Rad Laboratories, Inc
- Beckman Coulter, Inc(Danaher)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Genomics In Cancer Care Market - By Product and Service
1.3.2 Genomics In Cancer Care Market - By Technology
1.3.3 Genomics In Cancer Care Market - By Application
1.3.4 Genomics In Cancer Care Market - By End User
1.3.5 Genomics In Cancer Care Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. GENOMICS IN CANCER CARE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. GENOMICS IN CANCER CARE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. GENOMICS IN CANCER CARE MARKET - GLOBAL MARKET ANALYSIS
6.1. GENOMICS IN CANCER CARE - GLOBAL MARKET OVERVIEW
6.2. GENOMICS IN CANCER CARE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. GENOMICS IN CANCER CARE MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT AND SERVICE
7.1. OVERVIEW
7.2. PRODUCT AND SERVICE MARKET FORECASTS AND ANALYSIS
7.3. INSTRUMENTS
7.3.1. Overview
7.3.2. Instruments Market Forecast and Analysis
7.4. CONSUMABLES
7.4.1. Overview
7.4.2. Consumables Market Forecast and Analysis
7.5. SOFTWARE AND SERVICE
7.5.1. Overview
7.5.2. Software and Service Market Forecast and Analysis
8. GENOMICS IN CANCER CARE MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. GENE SEQUENCING
8.3.1. Overview
8.3.2. Gene Sequencing Market Forecast and Analysis
8.4. PCR
8.4.1. Overview
8.4.2. PCR Market Forecast and Analysis
8.5. MICROARRAY NUCLEIC ACID EXTRACTION AND PURIFICATION
8.5.1. Overview
8.5.2. Microarray Nucleic Acid Extraction and Purification Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. GENOMICS IN CANCER CARE MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. DIAGNOSTIC
9.3.1. Overview
9.3.2. Diagnostic Market Forecast and Analysis
9.4. DRUG DELIVERY
9.4.1. Overview
9.4.2. Drug Delivery Market Forecast and Analysis
9.5. PRECISION MEDICINE
9.5.1. Overview
9.5.2. Precision Medicine Market Forecast and Analysis
9.6. RESEARCH
9.6.1. Overview
9.6.2. Research Market Forecast and Analysis
10. GENOMICS IN CANCER CARE MARKET - REVENUE AND FORECASTS TO 2028 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS
10.3.1. Overview
10.3.2. Hospitals Market Forecast and Analysis
10.4. DIAGNOSTICS LABORATORIES
10.4.1. Overview
10.4.2. Diagnostics Laboratories Market Forecast and Analysis
10.5. ACADEMIC AND RESEARCH INSTITUTES
10.5.1. Overview
10.5.2. Academic and Research Institutes Market Forecast and Analysis
11. GENOMICS IN CANCER CARE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Genomics In Cancer Care Market Overview
11.1.2 North America Genomics In Cancer Care Market Forecasts and Analysis
11.1.3 North America Genomics In Cancer Care Market Forecasts and Analysis - By Product and Service
11.1.4 North America Genomics In Cancer Care Market Forecasts and Analysis - By Technology
11.1.5 North America Genomics In Cancer Care Market Forecasts and Analysis - By Application
11.1.6 North America Genomics In Cancer Care Market Forecasts and Analysis - By End User
11.1.7 North America Genomics In Cancer Care Market Forecasts and Analysis - By Countries
11.1.7.1 United States Genomics In Cancer Care Market
11.1.7.1.1 United States Genomics In Cancer Care Market by Product and Service
11.1.7.1.2 United States Genomics In Cancer Care Market by Technology
11.1.7.1.3 United States Genomics In Cancer Care Market by Application
11.1.7.1.4 United States Genomics In Cancer Care Market by End User
11.1.7.2 Canada Genomics In Cancer Care Market
11.1.7.2.1 Canada Genomics In Cancer Care Market by Product and Service
11.1.7.2.2 Canada Genomics In Cancer Care Market by Technology
11.1.7.2.3 Canada Genomics In Cancer Care Market by Application
11.1.7.2.4 Canada Genomics In Cancer Care Market by End User
11.1.7.3 Mexico Genomics In Cancer Care Market
11.1.7.3.1 Mexico Genomics In Cancer Care Market by Product and Service
11.1.7.3.2 Mexico Genomics In Cancer Care Market by Technology
11.1.7.3.3 Mexico Genomics In Cancer Care Market by Application
11.1.7.3.4 Mexico Genomics In Cancer Care Market by End User
11.2. EUROPE
11.2.1 Europe Genomics In Cancer Care Market Overview
11.2.2 Europe Genomics In Cancer Care Market Forecasts and Analysis
11.2.3 Europe Genomics In Cancer Care Market Forecasts and Analysis - By Product and Service
11.2.4 Europe Genomics In Cancer Care Market Forecasts and Analysis - By Technology
11.2.5 Europe Genomics In Cancer Care Market Forecasts and Analysis - By Application
11.2.6 Europe Genomics In Cancer Care Market Forecasts and Analysis - By End User
11.2.7 Europe Genomics In Cancer Care Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Genomics In Cancer Care Market
11.2.7.1.1 Germany Genomics In Cancer Care Market by Product and Service
11.2.7.1.2 Germany Genomics In Cancer Care Market by Technology
11.2.7.1.3 Germany Genomics In Cancer Care Market by Application
11.2.7.1.4 Germany Genomics In Cancer Care Market by End User
11.2.7.2 France Genomics In Cancer Care Market
11.2.7.2.1 France Genomics In Cancer Care Market by Product and Service
11.2.7.2.2 France Genomics In Cancer Care Market by Technology
11.2.7.2.3 France Genomics In Cancer Care Market by Application
11.2.7.2.4 France Genomics In Cancer Care Market by End User
11.2.7.3 Italy Genomics In Cancer Care Market
11.2.7.3.1 Italy Genomics In Cancer Care Market by Product and Service
11.2.7.3.2 Italy Genomics In Cancer Care Market by Technology
11.2.7.3.3 Italy Genomics In Cancer Care Market by Application
11.2.7.3.4 Italy Genomics In Cancer Care Market by End User
11.2.7.4 Spain Genomics In Cancer Care Market
11.2.7.4.1 Spain Genomics In Cancer Care Market by Product and Service
11.2.7.4.2 Spain Genomics In Cancer Care Market by Technology
11.2.7.4.3 Spain Genomics In Cancer Care Market by Application
11.2.7.4.4 Spain Genomics In Cancer Care Market by End User
11.2.7.5 United Kingdom Genomics In Cancer Care Market
11.2.7.5.1 United Kingdom Genomics In Cancer Care Market by Product and Service
11.2.7.5.2 United Kingdom Genomics In Cancer Care Market by Technology
11.2.7.5.3 United Kingdom Genomics In Cancer Care Market by Application
11.2.7.5.4 United Kingdom Genomics In Cancer Care Market by End User
11.2.7.6 Rest of Europe Genomics In Cancer Care Market
11.2.7.6.1 Rest of Europe Genomics In Cancer Care Market by Product and Service
11.2.7.6.2 Rest of Europe Genomics In Cancer Care Market by Technology
11.2.7.6.3 Rest of Europe Genomics In Cancer Care Market by Application
11.2.7.6.4 Rest of Europe Genomics In Cancer Care Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Genomics In Cancer Care Market Overview
11.3.2 Asia-Pacific Genomics In Cancer Care Market Forecasts and Analysis
11.3.3 Asia-Pacific Genomics In Cancer Care Market Forecasts and Analysis - By Product and Service
11.3.4 Asia-Pacific Genomics In Cancer Care Market Forecasts and Analysis - By Technology
11.3.5 Asia-Pacific Genomics In Cancer Care Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Genomics In Cancer Care Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Genomics In Cancer Care Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Genomics In Cancer Care Market
11.3.7.1.1 Australia Genomics In Cancer Care Market by Product and Service
11.3.7.1.2 Australia Genomics In Cancer Care Market by Technology
11.3.7.1.3 Australia Genomics In Cancer Care Market by Application
11.3.7.1.4 Australia Genomics In Cancer Care Market by End User
11.3.7.2 China Genomics In Cancer Care Market
11.3.7.2.1 China Genomics In Cancer Care Market by Product and Service
11.3.7.2.2 China Genomics In Cancer Care Market by Technology
11.3.7.2.3 China Genomics In Cancer Care Market by Application
11.3.7.2.4 China Genomics In Cancer Care Market by End User
11.3.7.3 India Genomics In Cancer Care Market
11.3.7.3.1 India Genomics In Cancer Care Market by Product and Service
11.3.7.3.2 India Genomics In Cancer Care Market by Technology
11.3.7.3.3 India Genomics In Cancer Care Market by Application
11.3.7.3.4 India Genomics In Cancer Care Market by End User
11.3.7.4 Japan Genomics In Cancer Care Market
11.3.7.4.1 Japan Genomics In Cancer Care Market by Product and Service
11.3.7.4.2 Japan Genomics In Cancer Care Market by Technology
11.3.7.4.3 Japan Genomics In Cancer Care Market by Application
11.3.7.4.4 Japan Genomics In Cancer Care Market by End User
11.3.7.5 South Korea Genomics In Cancer Care Market
11.3.7.5.1 South Korea Genomics In Cancer Care Market by Product and Service
11.3.7.5.2 South Korea Genomics In Cancer Care Market by Technology
11.3.7.5.3 South Korea Genomics In Cancer Care Market by Application
11.3.7.5.4 South Korea Genomics In Cancer Care Market by End User
11.3.7.6 Rest of Asia-Pacific Genomics In Cancer Care Market
11.3.7.6.1 Rest of Asia-Pacific Genomics In Cancer Care Market by Product and Service
11.3.7.6.2 Rest of Asia-Pacific Genomics In Cancer Care Market by Technology
11.3.7.6.3 Rest of Asia-Pacific Genomics In Cancer Care Market by Application
11.3.7.6.4 Rest of Asia-Pacific Genomics In Cancer Care Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Genomics In Cancer Care Market Overview
11.4.2 Middle East and Africa Genomics In Cancer Care Market Forecasts and Analysis
11.4.3 Middle East and Africa Genomics In Cancer Care Market Forecasts and Analysis - By Product and Service
11.4.4 Middle East and Africa Genomics In Cancer Care Market Forecasts and Analysis - By Technology
11.4.5 Middle East and Africa Genomics In Cancer Care Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Genomics In Cancer Care Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Genomics In Cancer Care Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Genomics In Cancer Care Market
11.4.7.1.1 South Africa Genomics In Cancer Care Market by Product and Service
11.4.7.1.2 South Africa Genomics In Cancer Care Market by Technology
11.4.7.1.3 South Africa Genomics In Cancer Care Market by Application
11.4.7.1.4 South Africa Genomics In Cancer Care Market by End User
11.4.7.2 Saudi Arabia Genomics In Cancer Care Market
11.4.7.2.1 Saudi Arabia Genomics In Cancer Care Market by Product and Service
11.4.7.2.2 Saudi Arabia Genomics In Cancer Care Market by Technology
11.4.7.2.3 Saudi Arabia Genomics In Cancer Care Market by Application
11.4.7.2.4 Saudi Arabia Genomics In Cancer Care Market by End User
11.4.7.3 U.A.E Genomics In Cancer Care Market
11.4.7.3.1 U.A.E Genomics In Cancer Care Market by Product and Service
11.4.7.3.2 U.A.E Genomics In Cancer Care Market by Technology
11.4.7.3.3 U.A.E Genomics In Cancer Care Market by Application
11.4.7.3.4 U.A.E Genomics In Cancer Care Market by End User
11.4.7.4 Rest of Middle East and Africa Genomics In Cancer Care Market
11.4.7.4.1 Rest of Middle East and Africa Genomics In Cancer Care Market by Product and Service
11.4.7.4.2 Rest of Middle East and Africa Genomics In Cancer Care Market by Technology
11.4.7.4.3 Rest of Middle East and Africa Genomics In Cancer Care Market by Application
11.4.7.4.4 Rest of Middle East and Africa Genomics In Cancer Care Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Genomics In Cancer Care Market Overview
11.5.2 South and Central America Genomics In Cancer Care Market Forecasts and Analysis
11.5.3 South and Central America Genomics In Cancer Care Market Forecasts and Analysis - By Product and Service
11.5.4 South and Central America Genomics In Cancer Care Market Forecasts and Analysis - By Technology
11.5.5 South and Central America Genomics In Cancer Care Market Forecasts and Analysis - By Application
11.5.6 South and Central America Genomics In Cancer Care Market Forecasts and Analysis - By End User
11.5.7 South and Central America Genomics In Cancer Care Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Genomics In Cancer Care Market
11.5.7.1.1 Brazil Genomics In Cancer Care Market by Product and Service
11.5.7.1.2 Brazil Genomics In Cancer Care Market by Technology
11.5.7.1.3 Brazil Genomics In Cancer Care Market by Application
11.5.7.1.4 Brazil Genomics In Cancer Care Market by End User
11.5.7.2 Argentina Genomics In Cancer Care Market
11.5.7.2.1 Argentina Genomics In Cancer Care Market by Product and Service
11.5.7.2.2 Argentina Genomics In Cancer Care Market by Technology
11.5.7.2.3 Argentina Genomics In Cancer Care Market by Application
11.5.7.2.4 Argentina Genomics In Cancer Care Market by End User
11.5.7.3 Rest of South and Central America Genomics In Cancer Care Market
11.5.7.3.1 Rest of South and Central America Genomics In Cancer Care Market by Product and Service
11.5.7.3.2 Rest of South and Central America Genomics In Cancer Care Market by Technology
11.5.7.3.3 Rest of South and Central America Genomics In Cancer Care Market by Application
11.5.7.3.4 Rest of South and Central America Genomics In Cancer Care Market by End User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. GENOMICS IN CANCER CARE MARKET, KEY COMPANY PROFILES
13.1. ILLUMINA INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. AGILENT TECHNOLOGIES, INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. THERMO FISHER SCIENTIFIC INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. PERKINELMER, INC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. QIAGEN
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. ABBOTT
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. BGI
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. F. HOFFMANN LA ROCHE AG
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. BIO RAD LABORATORIES, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. BECKMAN COULTER, INC( DANAHER)
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. Illumina Inc.
2. Agilent Technologies, Inc.
3. Thermo Fisher Scientific Inc.
4. PerkinElmer, Inc.
5. QIAGEN
6. Abbott
7. BGI
8. F. Hoffmann La Roche AG
9. Bio Rad Laboratories, Inc.
10. Beckman Coulter, Inc(Danaher)
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For